Related Experiment Video
Updated: Jun 20, 2026

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
Published on: May 25, 2017
Clostridium difficile: controversies and approaches to management
Martijn P Bauer1, Jaap T van Dissel, Ed J Kuijper
1Department of Infectious Diseases, The Netherlands.
Clostridium difficile infection (CDI) management faces challenges with treatment refractoriness and recurrence. New antimicrobial therapies and alternative treatments like immunotherapy are under investigation, but evidence-based guidance is still pending.
Area of Science:
- Infectious Diseases
- Microbiology
- Pharmacology
Background:
- Clostridium difficile infection (CDI) incidence is rising, presenting significant clinical management challenges.
- Key issues in CDI management include treatment refractoriness and high recurrence rates.
Purpose of the Study:
- To review recent advancements in antimicrobial therapy for CDI.
- To explore emerging alternative treatment modalities for managing CDI.
Main Methods:
- Literature review of recent clinical trials and studies on CDI treatments.
- Analysis of antimicrobial agents, immunotherapy, and faecotherapy for CDI.
Main Results:
- Oral vancomycin demonstrates superiority over metronidazole for severe CDI.
- New antimicrobials like nitazoxanide and fidaxomicin show promise; their roles require further establishment.
- Intravenous antibodies may reduce CDI recurrence; probiotics lack supporting evidence, and faecotherapy trials are ongoing.
Conclusions:
- Current evidence-based guidance for managing refractory CDI and preventing recurrence is lacking.
- Clinical trial results for novel antimicrobials, immunotherapy, and faecotherapy are critically needed.
Related Concept Videos
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Dysbiosis of the Gut Microbiota
Clinical Significance of Antibiotic Resistance
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Endocarditis III: Medical Management
